Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDRL
226
DELISTED
Seadrill Limited Common Stock
SDRL
| $41.3M | 0.1% |
3,421
-3,903
| -53% | -$46.1M |
|
227
Micron Technology
MU
$981B
| $41.3M | 0.1% |
+2,361,836
| New | +$34.2M |
|
|
FLIR
228
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $41M | 0.1% |
1,305,960
-548,400
| -30% | -$17.1M |
|
229
Healthpeak Properties
DOC
$14.1B
| $40.8M | 0.1% |
1,095,145
-549,000
| -33% | -$21.4M |
|
230
TE Connectivity
TEL
$63.3B
| $40.8M | 0.1% |
+788,000
| New | +$39.5M |
|
|
GRFS
231
Grifois
GRFS
$5.44B
| $40.7M | 0.1% |
2,685,308
-56,000
| -2% | -$871K |
|
232
Ross Stores
ROST
$80.8B
| $40.6M | 0.1% |
1,114,400
+448,472
| +67% | +$15.3M |
|
233
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $40.5M | 0.1% |
+994,600
| New | +$39.4M |
|
234
Oneok
OKE
$57.7B
| $40.5M | 0.1% |
868,300
-632,094
| -42% | -$27.4M |
|
|
MON
235
DELISTED
Monsanto Co
MON
| $40.2M | 0.1% |
385,600
-136,100
| -26% | -$13.7M |
|
|
CSGS
236
DELISTED
CSG Systems International
CSGS
| $40.1M | 0.1% |
1,600,722
+59,200
| +4% | +$1.43M |
|
237
Enterprise Products Partners
EPD
$81.8B
| $40.1M | 0.1% |
1,313,646
+197,000
| +18% | +$6.02M |
|
238
Franklin Resources
BEN
$16.9B
| $39.8M | 0.1% |
787,000
-836,600
| -52% | -$40.4M |
|
|
PCYC
239
DELISTED
PHARMACYCLICS INC
PCYC
| $39.5M | 0.1% |
+285,500
| New | +$31.7M |
|
|
ANN
240
DELISTED
ANN INC
ANN
| $39.3M | 0.1% |
1,084,200
-485,300
| -31% | -$16.6M |
|
241
Genuine Parts
GPC
$18.6B
| $39.2M | 0.1% |
+484,800
| New | +$39.3M |
|
242
CorVel
CRVL
$3.09B
| $38.7M | 0.09% |
3,138,600
+65,400
| +2% | +$737K |
|
243
Unilever
UL
$134B
| $38.6M | 0.09% |
888,747
+654,223
| +279% | +$29.7M |
|
244
Visteon
VC
$2.83B
| $38.1M | 0.09% |
503,500
-160,700
| -24% | -$11.2M |
|
245
Credit Acceptance
CACC
$5.94B
| $38M | 0.09% |
342,800
| – | – |
|
246
Compañía de Minas Buenaventura
BVN
$8.84B
| $37.9M | 0.09% |
3,233,300
+1,612,100
| +99% | +$21.3M |
|
247
Berkshire Hathaway Class B
BRK.B
$1.11T
| $37.8M | 0.09% |
+333,000
| New | +$38.4M |
|
248
Tyson Foods
TSN
$19.9B
| $37.8M | 0.09% |
+1,336,100
| New | +$38.7M |
|
249
Parker-Hannifin
PH
$134B
| $37.7M | 0.09% |
+346,350
| New | +$35.7M |
|
250
Core Laboratories
CLB
$570M
| $37.6M | 0.09% |
222,500
+5,000
| +2% | +$776K |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.